News FDA promotes faster digital health regulation Three new papers outline provisions in 21st Century Cures Act
News FDA approves Indivior's long-lasting opioid withdrawal thera... Monthly injection will help addicts manage withdrawal symptoms
News FDA to encourage approval of nicotine replacement therapies FDA commissioner wants to create new pathway
News Catalyst to re-submit rare disease drug after trial success Already approved in EU, Catalyst aiming for FDA filing next year.
News FDA encourages cheap abuse-deterrent painkillers Regulator waiting for non-opioid alternatives to reach the market
News Roche double trial success could expand use of two new drugs A double trial success from Roche sees it eyeing a combination therapy in lucrative first-line lung cancer, and wider use of its just-approved haemophilia drug, Hemlibra.
News Scribe raises $155m in IPO, as Apnimed pitches for $150m Gene-editing specialist Scribe becomes the 14th biotech to list on the Nasdaq this year, as sleep apnoea drug developer Apnimed prices its listing.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
